Document is current
Any future updates will be listed below
-
Authors
Papp, Tímea https://orcid.org/0000-0001-6266-4601
Rokszin, György
Kiss, Zoltán
Becker, Dávid
Merkely, Béla
Járai, Zoltán
Jánosi, András
Csanádi, Zoltán
-
Funding
Funding for this research was provided by:
Hungarian Society of Cardiology
University of Debrecen Program for Scientific Publication
- License Information
-
More Information
Article History
Received: 7 May 2024
Accepted: 22 July 2024
First Online: 13 August 2024
Declarations
:
: György Rokszin is employed by the company RxTarget Ltd. His contribution to this study analysis was financially compensated by the Hungarian Society of Cardiology. Béla Merkely reports grants or contracts from Medtronic and Boston Scientific, and personal fees from Biotronik and Abbott. Zoltán Járai reports payment or honoraria from Bayer, Boehringer, Pfizer, Richter Gedeon, Egis, Krka, Berlin Chemie – Menarini, Novo Nordisk, support for attending meetings from Egis, advisory board membership at Novo Nordisk, and board membership at the European Society of Hypertension, Hungarian Society of Hypertension, Hungarian Society of Cardiology. Tímea Papp, Zoltán Kiss, Dávid Becker, Andrási Jánosi and Zoltán Csanádi declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
: Anonymized data provided by the National Health Insurance Fund for this research did not contain any personal information which could be used to identify the patients. The study protocol was reviewed and confirmed by the National Health Insurance Fund (identification number: I043/125/2021) and they provided us the anonymized database which was later used for statistical analysis.
